Non-invasive and radiation-free assessment for early rule-out of significant CAD
On a Mission to Transform Early Cardiac Diagnostics
Introducing CADScor®System- an advanced acoustic-based diagnostic aid to easily and quickly rule out significant coronary artery disease at point of care.*
Use CADScor®System to Rule-Out Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*
Can help save costs of more advanced CAD diagnostics in up to 35% of patients¹
Rapid and easy to use, with clear results at point of care
Quickly and easily rule-out significant CAD with at least 96% Confidence (Negative Predictive Value) ¹
CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. The system calculates a patient-specific CAD-score, and couples it with risk factors to rapidly indicate the patient’s risk of significant coronary stenosis for immediate risk stratification, prior to potential secondary evaluation.1 CADScor®System has been used in over 29,000 patient assessments2 and has CE-marking and FDA De Novo clearance.
Physicians’ Experiences Using CADScor®System
Explore customer feedbackSchedule a Demo of CADScor®System
Schedule a free demo of CADScor® System and learn how to quickly and easily rule out significant CAD in symptomatic patients at point of care.*
Latest News
See all news
June 9, 2023
Announcement from Acarix's extra general meeting
May 22, 2023
Notice of Extra General Meeting in Acarix AB
- User manual US-FDA v.12.Y, prevalence 10,7%
- Based on commercial patch use since 2017